
Boots launches UK pharmacy medical cannabis prescribing service
Representative photo ยท Photo: Stacey Harris / Wikimedia Commons, CC BY-SA 2.0
Boots has launched a pioneering online service to prescribe medical cannabis for eligible UK patients suffering from chronic pain, anxiety or insomnia.
In a notable first for a British high street pharmacy, Boots has announced the launch of an online service to prescribe medical cannabis for eligible individuals. The initiative is aimed at patients in the UK aged 25 and older who deal with specific conditions such as chronic pain, insomnia, or anxiety.
The high street chain is rolling out its new platform, named SureLeaf, alongside a collaborative research initiative with the University of Nottingham. This study will focus on examining patient outcomes, treatment experiences, and prescribing practices specifically regarding chronic pain management.
Patients interested in the service must complete an online assessment. According to Boots, a clinical team will then review their suitability before inviting the candidate to a video consultation with a specialist.
Strict clinical safeguards have been built into the process. Boots confirmed that any potential prescription undergoes an independent review by a multidisciplinary clinical team, which includes a second independent consultant, before treatment can commence. Furthermore, the pharmacy stated that individuals must have already tried conventional treatments without success and will be subject to regular reviews.
Jamie Kerruish, chief healthcare officer at Boots, noted that millions struggle with ongoing pain where standard treatments fail to provide adequate relief, impacting daily activities like sleeping, working, and spending time with loved ones. He emphasized that the program is designed to help individuals explore appropriate options to manage symptoms and enhance quality of life.
Dr David Gwynne, medical director of the pharmacy's online service, stressed that medical cannabis is not suitable for everyone and requires careful evaluation on an individual basis. He highlighted that SureLeaf incorporates specialist oversight at every stage to ensure responsible, clinically led care.
Boots becomes the first UK high street pharmacy to offer online medical cannabis prescriptions.
Medicinal cannabis was legalised across the UK in 2018 following a high-profile case involving a young boy with severe epilepsy, and many private clinics have since provided access. While the NHS currently limits prescriptions to rare forms of epilepsy, specific chemotherapy side effects, and certain multiple sclerosis symptoms, private practitioners have treated various neurological and psychiatric conditions.
International research published this year by universities in Australia and England found limited evidence supporting cannabis for conditions like anxiety, post-traumatic stress disorder, or psychotic disorders, though some positive indications were noted for sleep improvement, Tourette syndrome symptoms, and reducing cannabis dependence.
Why it matters
This development marks a significant shift in how medical cannabis can be accessed through recognized high street healthcare providers in the United Kingdom, moving the treatment closer to mainstream pharmacy networks under strict clinical supervision. It directly affects adult patients dealing with persistent conditions like chronic pain and insomnia who have found limited success with conventional medications.
Sources
More like this

WHO Warns Antimicrobial Resistance Could Kill Millions

UK Blood Services Issue Urgent Appeal for 150,000 Donations Before Winter

Ministers Criticized Over Lack of Cost Data for NHS Maternity Unit Repairs

